1-5 of 5
Brian J. Druker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Luxeptinib (CG-806) targets FLT3 and clusters of kinases operative in acute myeloid leukemia

William G. Rice, Stephen B. Howell, Hongying Zhang, Nasrin Rastgoo, Andrea Local, Stephen E. Kurtz, Pierrette Lo, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Brian J. Druker, Jeffrey W. Tyner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther molcanther.0832.2021.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0832
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies

Joseph M. Gozgit, Matthew J. Wong, Scott Wardwell, Jeffrey W. Tyner, Marc M. Loriaux, Qurish K. Mohemmad, Narayana I. Narasimhan, William C. Shakespeare, Frank Wang, Brian J. Druker, Tim Clackson, Victor M. Rivera
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 1028–1035.
DOI: https://doi.org/10.1158/1535-7163.MCT-10-1044
Published: 08 June 2011
View article
PDF
Journal Articles

Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics

Lee-Yee Choong, Simin Lim, Marie Chiew-Shia Loh, Xiaohui Man, Yunhao Chen, Weiyi Toy, Mengfei Pan, Chien-Shing Chen, Anuradha Poonepalli, M. Prakash Hande, Puay-Hoon Tan, Manuel Salto-Tellez, Chow-Yin Wong, Nilesh Shah, Brian J. Druker, Yoon-Pin Lim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11): 2828–2842.
DOI: https://doi.org/10.1158/1535-7163.MCT-06-0809
Published: 19 November 2007
View article
PDF
Journal Articles

Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells

Yoon-Pin Lim, Lang-Shi Diong, Robert Qi, Brian J. Druker, Richard J. Epstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (12): 1369–1377.
Published: 05 January 2004
View article
PDF
Journal Articles

Overcoming Resistance to Imatinib by Combining Targeted Agents

Brian J. Druker
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (3): 225–226.
Published: 01 March 2003
View article
PDF